Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

 The effects of semaglutide on health-related quality of life in adults with type 2 diabetes and chronic kidney disease: FLOW trial

Sorry! It looks like the page you are trying to access contains materials that are still under embargo. Please come back and check again later.
Keywords
Diabetes
Congress short oral presentation
GLP-1 RA
Semaglutide
Clinical